Christian-H. Heeger: Does the CHAMPION AF Trial Signal a Potential Paradigm Shift in Stroke Prevention for AF?
Christian-H. Heeger, Head of the Department of Rhythmology at Asklepios Hamburg Altona, Professor of Electrophysiology at University of Lübeck, shared on LinkedIn:
”New evidence in stroke prevention for atrial fibrillation – a potential paradigm shift?
The CHAMPION AF trial is the first large randomized study evaluating the WATCHMAN FLX™ system as a first-line therapy compared to direct oral anticoagulants (DOACs).
Why does this matter?
DOACs remain the standard of care for stroke prevention in non-valvular atrial fibrillation.
However, long-term bleeding risk continues to be a major clinical concern.
Study overview (CHAMPION-AF):
- Randomized controlled trial with ~3,000 patients worldwide
- Comparison: Left atrial appendage closure (LAAC) vs. DOAC therapy
- Multi-year follow-up
Primary endpoints:
- Stroke, cardiovascular death, and systemic embolism (non-inferiority)
- Non-procedural bleeding (superiority)
Study objective:
To demonstrate that a one-time interventional approach can provide a safe and effective long-term alternative to chronic anticoagulation – even in patients without contraindications to oral anticoagulants.
What could this mean for clinical practice?
If confirmed, these findings could significantly expand the role of LAAC—potentially positioning it as an earlier treatment option in stroke prevention strategies for atrial fibrillation.
A highly anticipated study with the potential to reshape treatment pathways.
With Option and Champion patients after or during PVI will also benefit from this strategy!”
Stay updated with Hemostasis Today.
-
Jul 6, 2026, 04:36Sarah Richardson: On Capitol Hill, Speaking Up for Patients
-
Jul 5, 2026, 23:26Nominations Now Open for the First Nations Stroke Excellence Award – Stroke Foundation
-
Jul 5, 2026, 22:51Shahzaib Akram: What Are We Actually Seeing When a Sickling Test Goes Positive?
-
Jul 5, 2026, 21:474 Tips for Exercising with A Bleeding Disorder – Haemophilia Foundation Australia
-
Jul 5, 2026, 21:06Heghine Khachatryan: Toward Personalized Management of Glanzmann Thrombasthenia
-
Jul 5, 2026, 21:06Priyanka Kumari: IV Fluids and Isotonic Solution
-
Jul 5, 2026, 21:05Ahmed Rizq: Would You Thrombolyse a Stable Patient?
-
Jul 5, 2026, 21:03Emmanuel Obeng Ofori: Diagnosing Anaemia – Why Treating the Root Cause Matters More Than Simply Raising the Haemoglobin
-
Jul 5, 2026, 21:02Mohit Koladia: The Pharmacist’s Role in Stroke Prevention for Atrial Fibrillation